Gastric dumping syndrome classification: Difference between revisions
Jump to navigation
Jump to search
| (10 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gastric dumping syndrome}} | {{Gastric dumping syndrome}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{UA}} | ||
==Overview== | ==Overview== | ||
[[Gastric dumping syndrome|Dumping syndrome]] can be divided into | [[Gastric dumping syndrome|Dumping syndrome]] can be divided into early dumping and late dumping syndrome based upon the timeline of onset of [[symptoms]] and clinical features. | ||
==Classification== | ==Classification== | ||
Dumping syndrome may be classified based upon the timeline of the onset of [[symptoms]] and clinical features. The following table depicts the major classification systems of dumping syndrome :<ref name="pmid1549803">{{cite journal |vauthors=Eagon JC, Miedema BW, Kelly KA |title=Postgastrectomy syndromes |journal=Surg. Clin. North Am. |volume=72 |issue=2 |pages=445–65 |year=1992 |pmid=1549803 |doi= |url=}}</ref><ref name="pmid1990879">{{cite journal |vauthors=Miedema BW, Kelly KA |title=The Roux operation for postgastrectomy syndromes |journal=Am. J. Surg. |volume=161 |issue=2 |pages=256–61 |year=1991 |pmid=1990879 |doi= |url=}}</ref><ref name="pmid9279532">{{cite journal |vauthors=Vecht J, Gielkens HA, Frölich M, Lamers CB, Masclee AA |title=Vasoactive substances in early dumping syndrome: effects of dumping provocation with and without octreotide |journal=Eur. J. Clin. Invest. |volume=27 |issue=8 |pages=680–4 |year=1997 |pmid=9279532 |doi= |url=}}</ref> | |||
{| class="wikitable" | {| class="wikitable" style="margin: 1em auto 1em auto" | ||
! | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical Features | ||
!Early Dumping | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Early Dumping | ||
!Late Dumping | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Late Dumping | ||
|- | |- | ||
|'''Onset''' | |'''Onset''' | ||
| Line 19: | Line 19: | ||
|'''Risk Factor''' | |'''Risk Factor''' | ||
|[[Bariatrics|Bariatric]] [[Surgery]] | |[[Bariatrics|Bariatric]] [[Surgery]] | ||
|Hyperosmolar [[chyme]] | |[[Hyperosmolar]] [[chyme]] | ||
|- | |- | ||
|'''Mechanism''' | |'''Mechanism''' | ||
| | | | ||
* Increased release of multiple [[Gastrointestinal tract| | * Increased release of multiple [[Gastrointestinal tract|gastrointestinal]] [[Hormone|hormones]] | ||
* Decrease in [[Stomach|gastric]] [[volume]] | * Decrease in [[Stomach|gastric]] [[volume]] | ||
* Impaired [[retention]] | * Impaired [[retention]] | ||
* Possible | * Possible [[Pylorus|pyloric]] dysfunction | ||
| | | | ||
* Rapid [[glucose]] absorption | * Rapid [[glucose]] absorption | ||
| Line 40: | Line 40: | ||
* [[Borborygmus]] | * [[Borborygmus]] | ||
* [[Epigastric]] fullness | * [[Epigastric]] fullness | ||
* Abdominal [[Cramp|cramps]] | * [[Abdominal]] [[Cramp|cramps]] | ||
* [[Diaphoresis]] | * [[Diaphoresis]] | ||
* | * Desire to lie down | ||
* [[Headache]] | * [[Headache]] | ||
* [[Flushing]] | * [[Flushing]] | ||
| Line 60: | Line 60: | ||
| | | | ||
* [[Vasoactive]] agents ([[Vasoactive intestinal peptide|VIP]], [[Neurotensin]]) | * [[Vasoactive]] agents ([[Vasoactive intestinal peptide|VIP]], [[Neurotensin]]) | ||
* [[Incretin|Incretins]] (GIP, [[Glucagon-like peptide-1|GLP-1)]] | * [[Incretin|Incretins]] ([[Gastric inhibitory polypeptide]]- [[Gastric inhibitory polypeptide|GIP]], [[Glucagon-like peptide-1|glucagon like peptide]]- [[Glucagon-like peptide-1|GLP-1)]] | ||
* Glucose-modulating [[Hormone|hormones]] ([[Glucagon]], [[Insulin]]) | * [[Glucose]]-modulating [[Hormone|hormones]] ([[Glucagon]], [[Insulin]]) | ||
| | | | ||
* [[Incretin]] | * [[Incretin]] | ||
|- | |- | ||
|'''Common Complication''' | |'''Common Complication''' | ||
|Vasomotor [[Symptom|symptoms]] | |[[Vasomotor]] [[Symptom|symptoms]] | ||
|[[Hypoglycemia]] (high [[Insulin]]) | |[[Hypoglycemia]] (high [[Insulin]]) | ||
|} | |} | ||
Latest revision as of 18:15, 13 December 2017
|
Gastric dumping syndrome Microchapters |
|
Differentiating Gastric dumping syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gastric dumping syndrome classification On the Web |
|
American Roentgen Ray Society Images of Gastric dumping syndrome classification |
|
Risk calculators and risk factors for Gastric dumping syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Umar Ahmad, M.D.[2]
Overview
Dumping syndrome can be divided into early dumping and late dumping syndrome based upon the timeline of onset of symptoms and clinical features.
Classification
Dumping syndrome may be classified based upon the timeline of the onset of symptoms and clinical features. The following table depicts the major classification systems of dumping syndrome :[1][2][3]
| Clinical Features | Early Dumping | Late Dumping |
|---|---|---|
| Onset | 15-30 minutes after a meal | 60-180 minutes after a meal |
| Risk Factor | Bariatric Surgery | Hyperosmolar chyme |
| Mechanism | ||
| Symptoms |
|
|
| Hormones |
|
|
| Common Complication | Vasomotor symptoms | Hypoglycemia (high Insulin) |
References
- ↑ Eagon JC, Miedema BW, Kelly KA (1992). "Postgastrectomy syndromes". Surg. Clin. North Am. 72 (2): 445–65. PMID 1549803.
- ↑ Miedema BW, Kelly KA (1991). "The Roux operation for postgastrectomy syndromes". Am. J. Surg. 161 (2): 256–61. PMID 1990879.
- ↑ Vecht J, Gielkens HA, Frölich M, Lamers CB, Masclee AA (1997). "Vasoactive substances in early dumping syndrome: effects of dumping provocation with and without octreotide". Eur. J. Clin. Invest. 27 (8): 680–4. PMID 9279532.